This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Aveo Pharmaceuticals, Inc.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2025
Title: The Innovative Contributions of Steven Tyler
Introduction
Steven Tyler is a prominent inventor based in Boston, MA (US), known for his significant contributions to the field of biotechnology. With a total of 7 patents, he has made remarkable strides in developing therapies for cell proliferative diseases, particularly in cancer treatment.
Latest Patents
Among his latest patents are the Anti-ErbB3 antibodies, which are monoclonal antibodies designed to bind and inhibit the activation of the epidermal growth factor receptor-related member ErbB3/HER3. These antibodies hold promise for treating various cell proliferative diseases and disorders, including certain forms of cancer associated with the activation of ErbB3/HER3.
Career Highlights
Steven Tyler is currently associated with Aveo Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions that address critical health challenges, particularly in oncology.
Collaborations
He collaborates with talented professionals in the field, including Sylvie Vincent and Kristan Meetze, to enhance the impact of his research and inventions.
Conclusion
Steven Tyler's contributions to biotechnology and his innovative patents reflect his commitment to improving healthcare outcomes. His work continues to inspire advancements in cancer treatment and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile